"Three Distinct Stroma Types in Human Pancreatic Cancer Identified by Image Analysis of Fibroblast Subpopulations and Collagen"
https://t.co/G2DNkg0NtX
Jacks Lab (@LabJacks) researchers led by Dr. Tyler Jacks and collaborators demonstrated that the CD155/TIGIT axis is critical in maintaining immune evasion in #pancreatic adenocarcinoma.
📍 https://t.co/uBEIzsLhCM
Who will respond to immunotherapy?
This recent paper suggests that the tumor microenvironment falls into 4 categories and can predict therapeutic response: https://t.co/bQnkt6t0zn #AcademicTwitter@MDAndersonNews@BostonGeneCorp
Researchers show the importance of a dynamic synergistic relationship between patient cells with stromal fibroblasts, in a 3D perfused #vascular network, to accurately recapitulate a dynamic tumor microenvironment.
📌 https://t.co/S66ebcgzK2
Let's make sure that everyone with #PancreaticCancer gets the tablets they need to build strength for treatment and improve the quality of their life. We're calling on the NHS to set and meet prescription targets. 💊
Sign today. https://t.co/G8C5IhPAmA #TransformLivesPrescribe
Thanks to the brilliant work of all our collaborators, we will soon be publishing ‘Pancreatic enzyme replacement therapy in patients with pancreatic cancer’ - #PERT is a key component of #pancreaticcancer care but we are not doing enough to provide it to our patients yet!
I am extremely happy to have had the opportunity to present DIVERSA at the DEMO day @LaconNetwork#STARTUPCONGRESSGALICIA
DIVERSA. One technology, limitless applications. Let's start the therapeutic revolution.
Follow #DIVERSA here to keep updated 👇🏻
https://t.co/Iw5C8CTJmp
Researchers developed patient-derived xenograft models of #pancreas which could be used as a preclinical tool to better understand the biology of #PancreaticCancers and its underlying impact on effectiveness of therapeutic approaches.
📗 @SciReports
https://t.co/xc5HUQ3tS0
Pancreatic Cancer May Succumb to “Dual Cell” Approach
#Pancreaticcancer could be overcome by SLC7A11-silencing treatments that target both cancer cells and cancer-associated fibroblasts. Learn more: https://t.co/HsHWizIdzh
Scientists identify the PAR1‐Myc axis as a driver of ductal cell fates in premalignant #pancreas and pancreatic ductal #adenocarcinoma.
https://t.co/AN94mrDFir
Suppression of pancreatic ductal adenocarcinoma growth and metastasis by fibrillar collagens produced selectively by tumor cells
https://t.co/uWeWxqcInO #PancreaticCancer
Did you know that Pancreatic Cancer has the lowest survival rate of all cancers?
Check out the data of different european countries:
https://t.co/EYZvF3x141